Watch CNBC's full interview with Pfizer CEO Albert Bourla on Covid-19 pill

Pfizer CEO Albert Bourla sits down with CNBC's Meg Tirrell and the 'Squawk Box' team to discuss the latest on the company's Covid-19 pill, which cuts the risk of hospitalization and death by 89 percent in its clinical trials. Bourla breaks down when the pharmaceutical giant plans to file its medicine with the FDA for emergency use authorization and what it's doing to ramp up manufacturing.